News List
Subject Date
Aptose Enters into Exclusive Worldwide License Agreement with Hanmi Pharmaceutical for Clinical-Stage Myeloid Kinome Inhibitor HM43239 Nov 09, 2021
Hanmi Pharmaceutical to Release High Blood Pressure and Hyperlipidemia Drug in Russia Apr 23, 2021
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021 Apr 14, 2021
FDA Grants Fast Track Designation to Spectrum Pharmaceuticals’ Poziotinib Apr 14, 2021
Hanmi collaborated with MSD has launched Rosuzet the First Overseas Market in Mexico Mar 05, 2021
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs Jan 19, 2021
'Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines' Jan 12, 2021
Hanmi Pharmaceutical and Merck Enter into Licensing Agreement to Develop Efinopegdutide Sep 03, 2020
FDA Grants Fast Track Designation for Hanmi LAPSTriple Agonist Jul 22, 2020
Athenex Presents Interim Data from Oral Paclitaxel Phase II Study in Cutaneous Angiosarcoma at ASCO20 Virtual Scientific Program Jun 02, 2020
1 2 3 4 5 6 7 8 9 10